A Post-Market, Prospective, Multicenter, Single-Arm Trial of XenMatrix¿ AB Surgical Graft in All CDC Wound Class Ventral or Incisional Midline Hernias

Awarded By

Contributors

Start/End

  • May 1, 2016 - April 30, 2020